[go: up one dir, main page]

DE60134656D1 - Hilfsmittel und methoden zur transdermalen applikation von felodipin - Google Patents

Hilfsmittel und methoden zur transdermalen applikation von felodipin

Info

Publication number
DE60134656D1
DE60134656D1 DE60134656T DE60134656T DE60134656D1 DE 60134656 D1 DE60134656 D1 DE 60134656D1 DE 60134656 T DE60134656 T DE 60134656T DE 60134656 T DE60134656 T DE 60134656T DE 60134656 D1 DE60134656 D1 DE 60134656D1
Authority
DE
Germany
Prior art keywords
felodipin
additives
methods
transdermal application
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134656T
Other languages
English (en)
Inventor
Lino Tavares
Ihor Shevchuk
Mark Alfonso
Geraldine Marcenyac
Kirti H Valia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of DE60134656D1 publication Critical patent/DE60134656D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60134656T 2000-10-23 2001-10-23 Hilfsmittel und methoden zur transdermalen applikation von felodipin Expired - Lifetime DE60134656D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24251400P 2000-10-23 2000-10-23
PCT/US2001/049950 WO2002034206A2 (en) 2000-10-23 2001-10-23 Felodipine transdermal device and methods

Publications (1)

Publication Number Publication Date
DE60134656D1 true DE60134656D1 (de) 2008-08-14

Family

ID=22915068

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134656T Expired - Lifetime DE60134656D1 (de) 2000-10-23 2001-10-23 Hilfsmittel und methoden zur transdermalen applikation von felodipin

Country Status (9)

Country Link
EP (1) EP1328273B1 (de)
AT (1) ATE399551T1 (de)
AU (1) AU2002232755A1 (de)
CY (1) CY1108368T1 (de)
DE (1) DE60134656D1 (de)
DK (1) DK1328273T3 (de)
ES (1) ES2309107T3 (de)
PT (1) PT1328273E (de)
WO (1) WO2002034206A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305137A1 (de) * 2003-02-07 2004-08-26 Novosis Ag Transdermale therapeutische Abgabesysteme mit einem Butenolid
DE602005015679D1 (de) * 2004-01-14 2009-09-10 Lavipharm Lab Inc Transdermale abgabevorrichtung für dihydropyridin-artige calcium-antagonisten mit 2 fettsäuren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661971A1 (de) * 1991-12-02 1995-07-12 Sepracor, Inc. Verfahren und zusammensetzungen zur behandlung von hypertonie, angina und anderen erkrankungen unter verwendung von optisch reinem s(-) felodipin
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
AU2978400A (en) * 1999-02-02 2000-08-25 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices

Also Published As

Publication number Publication date
EP1328273B1 (de) 2008-07-02
WO2002034206A9 (en) 2003-04-17
ATE399551T1 (de) 2008-07-15
EP1328273A2 (de) 2003-07-23
WO2002034206A2 (en) 2002-05-02
PT1328273E (pt) 2008-09-23
EP1328273A4 (de) 2004-09-22
ES2309107T3 (es) 2008-12-16
CY1108368T1 (el) 2014-02-12
AU2002232755A1 (en) 2002-05-06
WO2002034206A3 (en) 2002-07-18
DK1328273T3 (da) 2008-10-20

Similar Documents

Publication Publication Date Title
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
DE60115618D1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
DK1316308T3 (da) Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger
DE60115842D1 (de) Ventilanordnung
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
PT1173201E (pt) Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
ATE222101T1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE60134656D1 (de) Hilfsmittel und methoden zur transdermalen applikation von felodipin
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
DE69917756D1 (de) Methoden zur behandlung von neurombedingten schmerzen
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
WO2002054996A3 (en) Terazosin transdermal device and methods
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE69922174D1 (de) Biomaterial zur behandlung von zahnfäule
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE472323T1 (de) Behandlung von statin-nebenwirkungen mit uridinderivaten
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition